The Effect of Dexmedetomidine on Airway Complications After Deep or Awake Extubation

• Status: Terminated
• Trial end date: 2018-04-23
• Target enrollment: 0
• Participant gender: All

Summary

The investigators aim to investigate the effect of dexmedetomidine on the perioperative respiratory complications in this patient population undergoing both awake and deep tracheal extubation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Massachusetts Eye and Ear Infirmary
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• Patients between 3 to 16 years of age undergoing adenotonsillectomy, with or without myringotomy or myringoplasty

• ASA 1 & 2

Exclusion Criteria:

• Known allergy or hypersensitivity reaction to dexmedetomidine

• Organ dysfunction (renal/hepatic failure or leukemia)

• Cardiac disease (congenital or acquired)

• Airway or thoracic malformation

• Cerebral palsy

• Hypotonia

• Need for premedication

• Current/recent upper respiratory infection (within four weeks prior to the surgery)

• Asthma

• Allergy or intolerance to clonidine

• Non-English speaking parents/patients.